Scientists at the UCSF-affiliated Gladstone Institutes have devised a new method that allows for the more efficient and complete reprogramming of skin cells into cells that are virtually indistinguishable from heart muscle cells.
February 20, 2014
February 19, 2014
Genetic testing can help doctors choose the most effective and economical drugs to prevent blood clots in the half a million patients in the U.S. who receive coronary stents each year, according to a new study led by a UCSF researcher.
December 16, 2013
Taxing sugar-sweetened beverages is likely to decrease consumption, resulting in lower rates of diabetes and heart disease, and these health benefits are expected to be greatest for the low-income, Hispanic and African-American Californians who are at highest risk of diabetes, according to a new analysis led by researchers at UC San Francisco.
December 06, 2013
UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
December 02, 2013
A commonly used heart monitor may be a simple tool for predicting the risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UCSF.
November 12, 2013
UCSF faculty members will discuss their cutting-edge approaches to researching and delivering health care on at Dreamforce 2013’s “Unusual Thinkers” track.
October 17, 2013
In recent years, studies have reported inconsistent findings regarding whether calcium supplements used to prevent fractures increase the risk of heart attack.
October 08, 2013
An individual’s race or ethnic background could be a determining factor when it comes to risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UCSF.
October 01, 2013
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
September 27, 2013
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.